Clinical significance of Gata‐1, Gata‐2, EKLF, and c‐MPL expression in acute myeloid leukemia
Rosa Ayala(Hospital Universitario 12 De Octubre), Florinda Gilsanz(Hospital Universitario HM Madrid), Amalía Díez(Universidad Complutense de Madrid), Joaquín Martínez‐López(Hospital Universitario 12 De Octubre), Enriqueta Albízua(Hospital Universitario HM Madrid)
Cited by 39
Related Papers
Teclistamab in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2022|1.2k
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
|New England Journal of Medicine|2023|719
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
|New England Journal of Medicine|2021|532
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
|Nature Medicine|2021|523